During the past decade, Kagoshima University conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kagoshima University" #1 sponsor was "Japan Rhabdomyosarcoma Study Group" with 2 trials, followed by "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored, "Diagram B.V." with 1 trials sponsored, "University of Toyama" with 1 trials sponsored and "Wakayama Medical University" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kagoshima University" #1 collaborator was "Niigata University Medical & Dental Hospital" with 2 trials as a collaborator, "Biosense Webster, Inc." with 1 trials as a collaborator and "Johnson & Johnson" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Kagoshima University" are "Gastrointestinal Stromal Tumor" (2 trials), "Metastatic Cancer" (2 trials), "Sarcoma" (2 trials), "Chronic Atrial Fibrillation" (1 trials) and "Esophageal Cancer" (1 trials). Many other conditions were trialed in "Kagoshima University" in a lesser frequency.

Most popular intervention types in "Kagoshima University" are "Drug" (5 trials), "Procedure" (4 trials), "Biological" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (2 trials), "dactinomycin" (2 trials), "radiation therapy" (2 trials), "vincristine sulfate" (2 trials) and "CFAE guided ablation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kagoshima University" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Kagoshima University". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kagoshima University, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kagoshima University, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Kagoshima University has several departments that took part in Clinical trials: "Kagoshima University Medical and Dental Hospital" - 11 trials, "Kagoshima IBD Gastroenterology Clinic" - 5 trials, "Department of surgical oncology and digestive surgery kagoshima university graduate school" - 2 trials